KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 146 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 3.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $12,613,000 | +10.5% | 1,961,588 | 0.0% | 0.02% | +21.1% |
| Q3 2021 | $11,416,000 | -58.5% | 1,961,588 | -26.3% | 0.02% | -53.7% |
| Q2 2021 | $27,484,000 | -2.1% | 2,663,177 | -0.2% | 0.04% | -2.4% |
| Q1 2021 | $28,070,000 | -32.0% | 2,668,199 | +0.1% | 0.04% | -37.3% |
| Q4 2020 | $41,276,000 | +30.6% | 2,666,416 | +23.2% | 0.07% | +13.6% |
| Q3 2020 | $31,608,000 | -19.2% | 2,164,900 | +4.8% | 0.06% | -40.4% |
| Q2 2020 | $39,110,000 | -6.0% | 2,064,900 | -4.6% | 0.10% | -44.4% |
| Q1 2020 | $41,587,000 | +1635.7% | 2,164,900 | +1631.9% | 0.18% | +1877.8% |
| Q4 2019 | $2,396,000 | – | 125,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $35,031,000 | 23.03% |
| Palo Alto Investors LP | 5,267,652 | $81,543,000 | 4.28% |
| Fairmount Funds Management LLC | 702,351 | $10,872,000 | 3.89% |
| Birchview Capital, LP | 188,000 | $2,910,000 | 1.68% |
| Mesirow Financial Investment Management, Inc. | 22,303 | $345,250,000 | 1.09% |
| EMERALD ADVISERS, LLC | 1,822,781 | $28,217,000 | 0.94% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,661,236 | $25,716,000 | 0.90% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,552,504 | $24,033,000 | 0.85% |
| Altium Capital Management LP | 133,951 | $2,074,000 | 0.77% |
| Hood River Capital Management LLC | 931,754 | $14,424,000 | 0.48% |